Superpower’s Post

💡Our CEO, George Eleftheriou, recently had the opportunity to discuss with Elena Fernandez Kleinlein at a Panel on Digital Applications Collecting Real-World Evidence, during a Johnson & Johnson Innovation-JLABS Symposium. The panel centered on utilizing non-invasive wearable devices and digital applications to measure patient outcomes and collect real-world data for more personalized and effective treatments. This has been a topic at the core of our work at Feel Therapeutics, as we strive to transform the approach to clinical trials and innovate the field of mental health care. ▶️Read more on what was discussed here: https://lnkd.in/ddGCumsn #DigitalPrecisionMedicine #MentalHealthCare #FeelTherapeutics #JLABSsymposium #JNJInnovation #MentalHealth #Neuroscience #DigitalPrecisionPsychiatry #MentalHealthInnovation 

1️⃣ Chiropractors, did you know… Universities like Harvard, Wake Forest, and Stanford have opened Redox centers dedicated to studying this innate function in the body. 2️⃣ Did you know? There are 10,000+ articles on PubMed.gov. 3️⃣ Did you know? The peer-reviewed scientific journal Antioxidants and Redox Signaling covers reduction-oxidation (redox) signaling research. 4️⃣ Did you know? Redox signaling is how the body naturally maintains proper balance of every system. 5️⃣ Did you know? There’s only one groundbreaking redox signaling technology that harnesses this innate function of the body. 📈True innovation is singular and pioneering. _ _ _ 👆Imagine experiencing unparalleled patient outcomes and practice innovation with the only technology that harnesses redox signaling. ▪ Lead the future of medicine. ▪ Create future equity. As an ASEA Associate, I invite you to explore the magical world of our stabilized redox technology for your practice at -> www.liveyoungerlonger.co

Can you think outside the box? 👆 Are you a health professional who says you want innovation? 🔬 ▶ I had a conversation with a functional chiropractor recently who was stuck in the old model of antioxidants being the heroes. ▶ They couldn't see beyond their current knowledge and inaccurately explained to me (an author of redox signaling) what redox signaling is. ❌ Don't be that doctor… - - - If a new idea or method challenges your current paradigm of understanding can you: ✅ Think expansively? ✅ Take a fresh perspective? Did you know that since 1997, new research has shifted our knowledge of antioxidants and oxidants? 💥 ▶ For example, we now know that oxidants trigger immune response, tissue regeneration, and cardiovascular health. ▶ That's why a peer-reviewed journal, "Antioxidants & Redox Signaling" is dedicated to studying these groundbreaking insights. 📚 ▶ These developments are reshaping how we approach cellular health, potentially influencing treatments and optimizing overall wellness. 👆 How can we evolve your approach from just recommending antioxidants to supporting the body's natural balance in more nuanced and effective ways? _ This evolving understanding of redox biology is part of a larger shift towards more personalized, systems-based approaches to health and medicine. Stay curious. Challenge assumptions. Embrace emerging science. Your patients depend on it. www.liveyoungerlonger.co

Dear Colleagues: We would like to highlight an invited article by Professor Sridhar Tayur in the Decision Sciences Journal (DSJ). One of the important aspects for articles published at DSJ is relevancy to decision-making. This article focuses on innovations in the US Transplantation System and addresses the important consideration of societal impact in the research that we do. The article is open access and can be downloaded from the link below #Decisionmaking #Societalimpact #Research #Healthcare Sincerely, Srinivas (Sri) Talluri, Ph.D. and Xenophon Koufteros Editors-in-Chief Decision Sciences Journal

DIPEx Switzerland 🇨🇭: Insights into the Brain Damage Module – In Progress It's #WorldBrainDay on July 22! 🧠 This annual action day is about raising awareness and educating people about neurological disorders that affect individuals all around the globe. 🌍 Sharing experiences from affected individuals and their loved ones makes an important contribution to understanding how #BrainDamage can change one's life. Surviving brain damage leaves traces—not only visible as motor deficits but also invisible as cognitive deficits, #fatigue, and post-traumatic distress. The following quote powerfully captures the impact of fear about potential future events. These insights can be a resource for other affected individuals and their loved ones, as well as for teaching health professionals. The #BrainDamage in progress illustrates acute care experiences, challenges, impacts on loved ones, #decisionmaking, lessons, and strategies. It will be available on our redesigned website, www.DIPEx.ch. University of Zurich – Institute of Biomedical Ethics and History of Medicine (IBME) ZHAW School of Health Sciences Picture: DALL-E #BrainInjury #Hirnverletzung

And which race and cultural people are behind big medicine research?! https://lnkd.in/gY4Uzr8i

Learn more about bolstering translational research to address women’s health needs and join the @NASEM Health and Medicine Division Forum on Regenerative Medicine and Forum on Temporomandibular Disorders for a public hybrid workshop on October 1. Conversations will explore opportunities in regenerative medicine to better understand the underlying biology and develop therapies for women. Register here: https://lnkd.in/gmRVFRCP #RegenMedForum #TemporomandibularDisorders #RegenerativeMedicine #WomensHealth 

Alhamdulillah, I am very grateful to share the publication of our study titled, "Community-Acquired Pneumonia with Acute Kidney Injury Complicated by Rhabdomyolysis: A Challenging Case Report in a Resource-Limited Setting," in the International Medical Case Reports Journal (ISSN: 492874), a peer-reviewed journal indexed in SCOPUS and PubMed (Q2). This case highlights the critical importance of early recognition and prompt management of community-acquired pneumonia (CAP) complicated by acute kidney injury (AKI) and rhabdomyolysis, even in resource-limited settings. With timely intervention, favorable outcomes are achievable despite significant challenges. I would like to extend my heartfelt gratitude to my co-authors: Dr. Mohamed Abdulahi Hassan , Dr. Abdullahi Abdirahman Omar , and Dr. Omar Hassan Badawi. Click on the link below to read and download the full article. https://lnkd.in/erZ-tkmp SIMAD University Faculty of Medicine and Health Sciences-SIMAD Hospitals. Dr.Sumait Hospitals

🔬 A recent pre-print has been published on the long-term effects of rapamycin. This study is the first of its kind, where participants received weekly doses of 5 or 10 mg over 48 weeks and placebo groups for comparison. 💊 The results indicate that rapamycin holds promise in counteracting various aspects of age-related decline and enhancing overall health. Notably, the effects were found to be sex-dependent, showing the most benefit in women. 🙋♀️ The authors highlight that this is one of the first studies to present evidence that rapamycin can positively influence human longevity markers. They also stress the importance of individualized dosing to optimize outcomes. 💡 This research positions rapamycin as a potentially pivotal player in the future of longevity medicine—offering not just extended lifespan but improved quality of life. 💪 It is important to note that all these results come from a pre-print, so they might contain errors. It has yet to be evaluated by the medical community. Read the full article.👇 https://lnkd.in/d4VHPhGK #Longevity #Science #Health #Rapamycin

Alzheimer's Agitation Treatment Research Study Seeking Participants: Researchers from Johns Hopkins University, Tufts Medical Center, and McLean Hospital are investigating the use of an FDA-approved drug called dronabinol (Marinol) to treat agitation and aggression in people with Alzheimer's. Learn more about the study and how to participate here: https://lnkd.in/eQJ3c_We